Health Care & Life Sciences » Pharmaceuticals | Medicure Inc.

Medicure Inc.

Medicure Inc.
Stock Exchange Other OTC
EPS
 $0.02
Market Cap
 $57.69 M
Shares Outstanding
 15.74 M
Public Float
 9.79 M
Medicure Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
 CAD0.02
Market Cap
 CAD75.41 M
Shares Outstanding
 15.52 M
Public Float
 12.82 M

Profile

Address
1250 Waverley Street
Winnipeg Manitoba R3T 6C6
Canada
Employees -
Website http://www.medicure.com
Updated 07/08/2019
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of human therapeutics. It focuses on the marketing and distribution ofits acute care cardiovascular drug, AGGRASTAT. The company was founded by Albert D.

Financials

View All
Created with Highcharts 5.0.14Medicure Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.2 5742 5742 0322 0321 6681 6683 6243 62411 49611 4963 9253 92520132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Medicure Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.2 6022 6028 9498 94922 08322 08329 30429 30427 13227 13229 10929 10920132014201520162017201805k10k15k20k25k30k35k

Gerald P. McDole
Independent Director
Bert D. Friesen
Chairman, President & Chief Executive Officer
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.